A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants
Clinical trial NCT04844424 · COMPLETED
Trial details
- NCT number
- NCT04844424
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2022-05-06
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.